CXCR1 and neoplasm: Taken together, these results suggest that Cc/Glt NM may act as a promising topical agent against PDAC in the clinic, as through local delivery, nano-curcumin exhibits favorable pharmacological properties to induce and cytocidal effect on both PDAC cell and xenograft tumor, respectively.